A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2011
12/14/2011	CN101612140B 一种双氯芬酸钾缓释微丸胶囊的制备方法 Preparation of a diclofenac potassium sustained-release pellets capsules
12/14/2011	CN101605546B 抑制含有多奈哌齐的贴剂的经时变色的方法 A method of inhibiting discoloration over time patch containing donepezil of
12/14/2011	CN101601842B 一种缓解和预防眼部疾病的保健用品及其制备方法 One kind of mitigation and prevention of eye diseases, health supplies and its preparation method
12/14/2011	CN101559159B 一种百合莲子口服液的配方及制备方法 Lily lotus oral formulation and preparation methods
12/14/2011	CN101524345B 一种由丙戊酸钠和注射用水组成的药物组合物的制备工艺 A process for preparing water for injection by VPA and pharmaceutical compositions
12/14/2011	CN101507766B 具有降血脂和保健功能的中药胶囊的制备方法及其用途 With lipid-lowering medicine and health care functions capsule preparation and use
12/14/2011	CN101500550B 增强促弹性活性的组合物 Enhanced elasticizing activity composition
12/14/2011	CN101491623B 一种用于治疗椎间盘突出症的复方独活桑寄生汤 For the treatment of disc herniation Compound live alone mistletoe soup
12/14/2011	CN101485697B 银杏酮酯分散片及其制备方法 Ginkgo Biloba tablet and its preparation method
12/14/2011	CN101448939B 用于导入核酸、寡核酸或其衍生物的冷冻干燥体 Freeze-dried product for introducing a nucleic acid, oligonucleic acid or derivative thereof
12/14/2011	CN101434574B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method
12/14/2011	CN101402680B 鲨鱼肝再生因子、其制备方法及其医药用途 Shark liver regeneration factor, their preparation and their medicinal uses
12/14/2011	CN101396347B 一种重组人血管内皮抑制素缓释微球的制备方法 A recombinant human endostatin release microsphere preparation
12/14/2011	CN101380475B 一种薄膜包衣预混剂的制备方法及其应用 Preparation of a film coating premixes and its application
12/14/2011	CN101332263B 降低冠心病血小板聚集率的中药及其制备方法 Chinese medicine and its preparation method reduces platelet aggregation rate of coronary heart disease
12/14/2011	CN101328475B 核酸分子nrn1sr1及其在制备抗癌药物中的应用 Nrn1sr1 nucleic acid molecule and its application in the preparation of anti-cancer drugs
12/14/2011	CN101327262B 清开灵栓剂 Qingkailing suppositories
12/14/2011	CN101313894B 质子泵抑制剂组合物冻干粉针剂 Proton pump inhibitor composition freeze-dried powder
12/14/2011	CN101312715B 药物组合物 The pharmaceutical composition of
12/14/2011	CN101305985B 一种咖啡酸聚乳酸共聚物纳米微球的制备方法 One kind of coffee polylactic acid copolymer nanospheres preparation
12/14/2011	CN101305982B 局部凝胶给药体系 Topical gel delivery system
12/14/2011	CN101301425B 治疗糖尿病的药物组合物 A pharmaceutical composition for treating diabetes
12/14/2011	CN101300001B 奈拉美仙的修饰释放型骨架片剂 Naira cents modified-release matrix tablets
12/14/2011	CN101277688B 包含甲福明和维达列汀的配制物 Contains metformin and vildagliptin formulation
12/14/2011	CN101269055B 盐酸氨溴索口腔崩解片及其制备方法 Ambroxol hydrochloride orally disintegrating tablets and preparation method
12/14/2011	CN101244097B 包含有藤黄的酸性活性成分的蜡质骨架缓释剂 Waxy release agent containing the skeleton of acidic active ingredient Garcinia
12/14/2011	CN101209247B 一种结肠靶向制剂的制备方法 Preparation of a colon targeting agents
12/14/2011	CN101204424B 清热解毒抗炎消肿的中药组合物及其制备方法 Inflammatory swelling detoxification Chinese medicine composition and its preparation method
12/14/2011	CN101199639B 一种治疗易激症的中药 An herbal treatment of irritable bowel syndrome
12/14/2011	CN101181266B 一种联苯苄唑乳胶剂及其制备方法 A benzyl yl latex and preparation method biphenyls
12/14/2011	CN101167765B 结肠靶向给药软胶囊及其制备方法 Colon targeted drug delivery soft capsule and its preparation method
12/14/2011	CN101152174B 一种稳定的利福霉素钠注射液的处方及制备方法 A stable rifamycin sodium injection of prescription and preparation methods
12/14/2011	CN101143190B 用于痔毒疮的中药制剂 Canker of Chinese medicine for hemorrhoids
12/14/2011	CN101069685B 固体口服剂型药物 The solid oral dosage form pharmaceutical
12/13/2011	US8076520 Phosphatidyl oligoglycerols
12/13/2011	US8076368 Percutaneous absorption type cerebral protective agent
12/13/2011	US8076335 Processes of making pharmaceutical formulations of antineoplastic agents
12/13/2011	US8076317 administering contraceptives comprising hormones in cycles
12/13/2011	US8076282 Composition for improving membrane composition and functioning of cells
12/13/2011	US8075919 Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
12/13/2011	US8075918 Electroplating a plurality of purified carbon nanocapsules onto a substrate; thermal conductivity, chemical resistance, non oxidizing
12/13/2011	US8075917 Composition for solubilization of paclitaxel and preparation method thereof
12/13/2011	US8075916 Poly(organophosphazene) hydrogels for drug delivery, preparation method thereof and use thereof
12/13/2011	US8075915 Composition and method of transmitting ultrasonic and electrical impulses using a physiologically compatible conductive agent
12/13/2011	US8075914 Controlled release melatonin
12/13/2011	US8075913 Method of producing a cationic liposomal preparation comprising a lipophilic compound
12/13/2011	US8075912 Autodestructive transdermal therapeutic system
12/13/2011	US8075911 Transparent transdermal nicotine delivery devices
12/13/2011	US8075910 Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
12/13/2011	US8075909 Contact lens based bioactive agent delivery system
12/13/2011	US8075908 Apparatus and method for reducing the occurrence of post-surgical adhesions
12/13/2011	US8075896 Method to enhance an immune response of nucleic acid vaccination
12/13/2011	US8075873 Method of preparing dry powder inhalation compositions
12/13/2011	US8075536 Power injectable port identification
12/13/2011	US8074644 Method of forming an aerosol for inhalation delivery
12/13/2011	DE202010017303U1 Trockenverarbeitung von Retigabin Dry processing of retigabine
12/13/2011	CA2559224C Drug delivery system based on polyethylene vinylacetate copolymers
12/13/2011	CA2547194C Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability
12/13/2011	CA2503396C Water-soluble meloxicam granules
12/13/2011	CA2482114C Solid dosage form comprising caffeine
12/13/2011	CA2476247C Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
12/13/2011	CA2452806C Water-soluble stabilized self-assembled polyelectrolytes
12/13/2011	CA2392666C Dextrin containing compositions for prevention of adhesions
12/13/2011	CA2386954C Methods of treating vascular diseases characterized by nitric oxide insufficiency
12/13/2011	CA2378373C Production of rhpbgd and new therapeutic methods for treating patients with acute intermittent porphyria (aip) and other porphyric diseases
12/13/2011	CA2267851C Bordetella strain expressing the fha hybrid, liposomes and vaccines
12/10/2011	CA2742340A1 Stratiform perforated biomatrices
12/09/2011	CA2802767A1 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
12/08/2011	WO2011153513A2 Nanoemulsion composition containing vitamin k
12/08/2011	WO2011153334A2 Bioadhesive compositions for epithelial drug delivery
12/08/2011	WO2011153284A1 Porous matrix drug core for lacrimal insert device
12/08/2011	WO2011153140A2 Antiperspirant compositions
12/08/2011	WO2011153120A1 Novel low molecular weight cationic lipids for oligonucleotide delivery
12/08/2011	WO2011153010A1 Methods of treatment of pancreatic cancer
12/08/2011	WO2011153009A1 Methods of treating bladder cancer
12/08/2011	WO2011152926A1 Pharmaceutical compositions and methods for administering the same
12/08/2011	WO2011152875A1 Chewable, swallowable and effervescent solid dosge form for oral delivery of pharmaeutical actives
12/08/2011	WO2011152810A1 Formulations comprising calcium, vitamin d and vitamin k for osteoporosis
12/08/2011	WO2011152809A2 Effervescent formulations comprising cephalosporin and clavulanic acid
12/08/2011	WO2011152808A1 Formulation comprising cefpodoxime proxetil and clavulanic acid
12/08/2011	WO2011152807A1 Pharmaceutical formulation comprising cefpodoxime proxetil and clavulanic acid
12/08/2011	WO2011152806A1 Production method for the effervescent formulation comprising cephalosporin and potassium clavulanate
12/08/2011	WO2011152803A1 Water soluble formulation comprising a combination of amlodipine and a statin
12/08/2011	WO2011152783A1 Formulations preserving bioactivity and methods of their preparation
12/08/2011	WO2011152755A1 Pharmaceutical composition for the treatment of disorders of the lower section of the urogenital system
12/08/2011	WO2011152751A1 6-decaprenyl-2,3-dimethoxy-5-methyl-1,4-benzoquinone-based composition and method for the production thereof
12/08/2011	WO2011152692A2 Anti-obesity cream composition containing fucoxanthin
12/08/2011	WO2011152689A2 Method for purifying fucoxanthin derived from seaweed
12/08/2011	WO2011152652A2 Aceclofenac slow-release preparation providing an optimum pharmacological clinical effect when administered once a day
12/08/2011	WO2011152297A1 Solid dispersion comprising triazole compound
12/08/2011	WO2011151824A1 Novel pharmaceutical compounds
12/08/2011	WO2011151786A2 Injectable formulation
12/08/2011	WO2011151733A2 Fexofenadine-based composition and preparation process therefor
12/08/2011	WO2011151722A2 Methods and compositions for oral pharmaceutical therapy
12/08/2011	WO2011151708A1 Gastroretentive dosage forms of gaba analogs
12/08/2011	WO2011151667A1 Antiviral compositions
12/08/2011	WO2011151454A1 Reducing defects in electronic apparatus
12/08/2011	WO2011151431A1 Oral vaccine comprising an antigen and a toll-like receptor agonist
12/08/2011	WO2011151418A2 Nanosusupension formulation comprising a polydimethylsiloxane hydrophobic phase
12/08/2011	WO2011151400A1 Process for making dry and stable hemostatic compositions

1 ... 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 ... 2991